The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorderStephen V. Faraone, Yufeng Wang, Diane Purper‐Ouakil et al.|Neuroscience & Biobehavioral Reviews|2021Cited by 1.4k
Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity DisorderRichard H. Weisler, Joel Young, Gregory W. Mattingly et al.|CNS Spectrums|2009Cited by 93
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderGregory W. Mattingly, D. Wayne Goodman, Richard H. Weisler et al.|BMC Psychiatry|2013Cited by 31
A clinician’s guide for navigating the world of attention deficit hyperactivity disorder medicationsGregory W. Mattingly, Joel Young|CNS Spectrums|2021Cited by 6